Rhenman & Partners Asset Management AB Diversified Active

Location: Stockholm, Sweden

CIK: 0001599882 · Show all filings

Period: Q3 2015 (← Previous) (Next →)

Filing Date: Oct 26, 2015

Total Value: $627M (100.0% shares, 0.0% debt)

Holdings (91)

AMGN Amgen Inc 3.0%
Value $18.67M Shares 135,000 Est. Cost $112.46 Unrealized +3.4%
Alexion Pharmaceuticals Inc 2.9%
Value $17.98M Shares 115,000 Est. Cost $164.46 Unrealized
MDT Medtronic Plc 2.8%
Value $17.74M Shares 265,000 Est. Cost $58.05 Unrealized -1.8%
UNH United Health Group Inc 2.7%
Value $17.05M Shares 147,000 Est. Cost $89.16 Unrealized +13.5%
LLY Eli Lilly & Co 2.5%
Value $15.48M Shares 185,000 Est. Cost $56.93 Unrealized +23.8%
Aetna Inc 2.4%
Value $15.1M Shares 138,000 Est. Cost $104.69 Unrealized
ELV Anthem Inc 2.4%
Value $14.98M Shares 107,000 Est. Cost $134.01 Unrealized -3.1%
ALKS Alkermes Plc 2.4%
Value $14.96M Shares 255,000 Est. Cost $55.56 Unrealized +18.8%
Celgene Corp 2.3%
Value $14.71M Shares 136,000 Est. Cost $113.27 Unrealized
HUM Humana Inc 2.3%
Value $14.32M Shares 80,000 Est. Cost $170.02 Unrealized 0.0%
Cigna Corp 2.3%
Value $14.3M Shares 105,900 Est. Cost $135.02 Unrealized
MCK McKesson Corp 2.3%
Value $14.25M Shares 77,000 Est. Cost $191.15 Unrealized +2.3%
HCA HCA Holdings Inc 2.2%
Value $13.93M Shares 180,000 Est. Cost $71.44 Unrealized +15.2%
PFE Pfizer Inc 2.1%
Value $13.22M Shares 421,000 Est. Cost $20.60 Unrealized 0.0%
Allergan Plc 2.0%
Value $12.5M Shares 46,000 Est. Cost $300.70 Unrealized
CAH Cardinal Health Inc 1.9%
Value $12.21M Shares 159,000 Est. Cost $60.16 Unrealized +3.5%
BDX Becton Dickinson & Co 1.9%
Value $12.07M Shares 91,000 Est. Cost $118.02 Unrealized +1.0%
INCY Incyte Corp Ltd 1.9%
Value $12.03M Shares 109,000 Est. Cost $70.56 Unrealized +58.9%
St Jude Medical Inc 1.9%
Value $11.99M Shares 190,000 Est. Cost $64.79 Unrealized
ABBV AbbVie Inc 1.8%
Value $11.43M Shares 210,000 Est. Cost $37.46 Unrealized +13.5%
BMY Bristol Myers Squibb Co 1.8%
Value $11.37M Shares 192,000 Est. Cost $39.46 Unrealized +12.9%
GILD Gilead Sciences Inc 1.8%
Value $11.29M Shares 115,000 Est. Cost $64.85 Unrealized +19.5%
VRTX Vertex Pharmaceuticals Inc 1.7%
Value $10.94M Shares 105,000 Est. Cost $106.88 Unrealized +20.2%
PRGO Perrigo Co Plc 1.6%
Value $10.22M Shares 65,000 Est. Cost $179.06 Unrealized +2.4%
CNC Centene Corp 1.5%
Value $9.49M Shares 175,000 Est. Cost $30.22 Unrealized +10.7%
CYH Community Health Syst Inc 1.5%
Value $9.409M Shares 220,000 Est. Cost $41.54 Unrealized +10.4%
CVS CVS Health Corp 1.5%
Value $9.359M Shares 97,000 Est. Cost $63.54 Unrealized +22.4%
BMRN BioMarin Pharmaceutical Inc 1.4%
Value $9.058M Shares 86,000 Est. Cost $85.04 Unrealized +57.1%
Health Net Inc 1.4%
Value $9.033M Shares 150,000 Est. Cost $60.22 Unrealized
EW Edwards Lifesciences Corp 1.4%
Value $8.815M Shares 62,000 Est. Cost $20.05 Unrealized +20.4%
Laboratory Corp of America Hgs 1.4%
Value $8.786M Shares 81,000 Est. Cost $121.84 Unrealized
Cempra Inc 1.3%
Value $8.296M Shares 298,000 Est. Cost $33.87 Unrealized
Express Scripts Hg Co 1.2%
Value $7.772M Shares 96,000 Est. Cost $87.52 Unrealized
REGN Regeneron Pharmaceuticals Inc 1.2%
Value $7.675M Shares 16,500 Est. Cost $334.35 Unrealized +59.7%
Nektar Therapeutics 1.2%
Value $7.54M Shares 688,000 Est. Cost $11.22 Unrealized
DXCM Dexcom Inc 1.1%
Value $7.212M Shares 84,000 Est. Cost $10.75 Unrealized +107.5%
Abiomed Inc 1.1%
Value $7.05M Shares 76,000 Est. Cost $44.80 Unrealized
Cerner Corp 1.1%
Value $6.955M Shares 116,000 Est. Cost $62.08 Unrealized
Intra-Cellular Therapies Inc 1.1%
Value $6.607M Shares 165,000 Est. Cost $19.23 Unrealized
ZBH Zimmer Biomet Hgs Inc 1.0%
Value $6.575M Shares 70,000 Est. Cost $92.02 Unrealized 0.0%
ACAD Acadia Pharmaceuticals Inc 1.0%
Value $6.482M Shares 196,000 Est. Cost $25.97 Unrealized +60.2%
JAZZ Jazz Pharmaceuticals Plc 1.0%
Value $6.202M Shares 46,700 Est. Cost $170.18 Unrealized +1.2%
ALNY Alnylam Pharmaceuticals Inc 1.0%
Value $6.107M Shares 76,000 Est. Cost $97.77 Unrealized +13.6%
UHS Universal Health Services Inc B 1.0%
Value $6.103M Shares 48,900 Est. Cost $105.74 Unrealized +26.0%
COR AmerisourceBergen Corp 1.0%
Value $5.984M Shares 63,000 Est. Cost $62.18 Unrealized +24.6%
Keryx Biopharmaceuticals Inc 0.9%
Value $5.502M Shares 1,563,000 Est. Cost $6.26 Unrealized
Intercept Pharmaceuticals Inc 0.8%
Value $5.308M Shares 32,000 Est. Cost $211.96 Unrealized
Endo International Plc 0.8%
Value $5.057M Shares 73,000 Est. Cost $81.34 Unrealized
ZELTIQ Aesthetics Inc 0.8%
Value $5.029M Shares 157,000 Est. Cost $29.93 Unrealized
SUPN Supernus Pharmaceuticals Inc 0.8%
Value $4.957M Shares 353,328 Est. Cost $8.32 Unrealized +123.4%
MRK Merck & Co Inc 0.8%
Value $4.939M Shares 100,000 Est. Cost $38.32 Unrealized +0.2%
Cooper Companies Inc (The) 0.8%
Value $4.912M Shares 33,000 Est. Cost $177.98 Unrealized
Medivation Inc 0.8%
Value $4.845M Shares 114,000 Est. Cost $57.90 Unrealized
Heartware Intl Inc 0.7%
Value $4.551M Shares 87,000 Est. Cost $55.99 Unrealized
Revance Therapeutics Inc 0.7%
Value $4.404M Shares 148,000 Est. Cost $24.34 Unrealized
Rite Aid Corp 0.6%
Value $4.037M Shares 665,000 Est. Cost $7.07 Unrealized
Mylan N.V. 0.6%
Value $4.026M Shares 100,000 Est. Cost $63.16 Unrealized
Clovis Oncology Inc 0.6%
Value $3.954M Shares 43,000 Est. Cost $50.89 Unrealized
Lion Biotechnologies Inc 0.6%
Value $3.935M Shares 683,108 Est. Cost $8.54 Unrealized
Cyberonics Inc 0.6%
Value $3.464M Shares 57,000 Est. Cost $64.95 Unrealized
Isis Pharmaceuticals Inc 0.5%
Value $3.234M Shares 80,000 Est. Cost $52.32 Unrealized
Kite Pharma Inc 0.5%
Value $3.174M Shares 57,000 Est. Cost $58.72 Unrealized
Celldex Therapeutics Inc 0.5%
Value $3.109M Shares 295,000 Est. Cost $17.85 Unrealized
Portola Pharmaceuticals Inc 0.5%
Value $3.026M Shares 71,000 Est. Cost $45.55 Unrealized
PODD Insulet Corp 0.5%
Value $2.85M Shares 110,000 Est. Cost $34.93 Unrealized -13.2%
Endologix Inc 0.4%
Value $2.808M Shares 229,000 Est. Cost $14.18 Unrealized
Ariad Pharmaceuticals Inc 0.4%
Value $2.511M Shares 430,000 Est. Cost $6.79 Unrealized
Orexigen Therapeutics Inc 0.4%
Value $2.509M Shares 1,189,000 Est. Cost $5.13 Unrealized
Catabasis Pharmaceuticals Inc 0.4%
Value $2.43M Shares 300,427 Est. Cost $11.73 Unrealized
ESPR Esperion Therapeutics Inc 0.4%
Value $2.359M Shares 100,000 Est. Cost $22.47 Unrealized +179.2%
MGNX Macrogenics Inc 0.4%
Value $2.312M Shares 107,959 Est. Cost $27.20 Unrealized +15.3%
HALO Halozyme Therapeutics Inc 0.4%
Value $2.31M Shares 172,000 Est. Cost $17.58 Unrealized +14.2%
Cepheid Inc 0.4%
Value $2.305M Shares 51,000 Est. Cost $47.98 Unrealized
OMCL Omnicell Inc 0.4%
Value $2.301M Shares 74,000 Est. Cost $32.97 Unrealized +8.6%
Rigel Pharmaceuticals Inc 0.4%
Value $2.285M Shares 925,000 Est. Cost $3.57 Unrealized
XNCR Xencor Inc 0.4%
Value $2.217M Shares 181,303 Est. Cost $14.68 Unrealized +33.3%
LXRX Lexicon Pharmaceuticals Inc 0.3%
Value $2.148M Shares 200,000 Est. Cost $7.86 Unrealized +38.9%
Chimerix Inc 0.3%
Value $2.139M Shares 56,000 Est. Cost $44.36 Unrealized
Tesaro Inc 0.3%
Value $2.041M Shares 50,899 Est. Cost $31.85 Unrealized
Achillion Pharmaceuticals Inc 0.3%
Value $1.935M Shares 280,000 Est. Cost $9.71 Unrealized
Tandem Diabetes Care Inc 0.3%
Value $1.841M Shares 209,000 Est. Cost $12.69 Unrealized
Mirati Therapeutics Inc 0.3%
Value $1.721M Shares 50,000 Est. Cost $31.48 Unrealized
Array BioPharma Inc 0.3%
Value $1.687M Shares 370,000 Est. Cost $4.79 Unrealized
Tetraphase Pharmaceuticals Inc 0.3%
Value $1.679M Shares 225,000 Est. Cost $21.39 Unrealized
Anthera Pharmaceuticals Inc 0.2%
Value $1.523M Shares 250,000 Est. Cost $3.59 Unrealized
Dynavax Technologies Corp 0.2%
Value $1.35M Shares 55,000 Est. Cost $23.42 Unrealized
Regulus Therapeutic Inc 0.2%
Value $1.308M Shares 200,000 Est. Cost $6.54 Unrealized
HOLX Hologic Inc 0.2%
Value $1.303M Shares 33,301 Est. Cost $24.29 Unrealized +63.3%
Avalanche Biotechnologies Inc 0.2%
Value $1.269M Shares 154,006 Est. Cost $23.02 Unrealized
Threshold Pharmaceuticals 0.1%
Value $820K Shares 201,537 Est. Cost $4.08 Unrealized
BIND Therapeutics Inc 0.1%
Value $596K Shares 133,535 Est. Cost $11.18 Unrealized